299 results on '"Prasad, N."'
Search Results
2. Electrical, magnetic, and Raman spectroscopic studies on Bi-modified YIG ceramics
- Author
-
Susneha, T., Someshwar, P., and Prasad, N. V.
- Published
- 2024
- Full Text
- View/download PDF
3. Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions
- Author
-
Sai Prasad N. Iyer, PhD, Christopher J. Pino, PhD, Lenar T. Yessayan, MD, Stuart L. Goldstein, MD, Matthew R. Weir, MD, Angela J. Westover, BS, David A. Catanzaro, PharmD, Kevin K. Chung, MD, and H. David Humes, MD
- Subjects
Surgery ,RD1-811 - Abstract
A stable, minimum physiological health status is required for patients to qualify for transplant or artificial organ support eligibility to ensure the recipient has enough reserve to survive the perioperative transplant period. Herein, we present a novel strategy to stabilize and improve patient clinical status through extracorporeal immunomodulation of systemic hyperinflammation with impact on multiple organ systems to increase eligibility and feasibility for transplant/device implantation. This involves treatment with the selective cytopheretic device (SCD), a cell-directed extracorporeal therapy shown to adhere and immunomodulate activated neutrophils and monocytes toward resolution of systemic inflammation. In this overview, we describe a case series of successful transition of pediatric and adult patients with multiorgan failure to successful transplant/device implantation procedures by treatment with the SCD in the following clinical situations: pediatric hemophagocytic lymphohistiocytosis, and adult hepatorenal and cardiorenal syndromes. Application of the SCD in these cases may represent a novel paradigm in increasing clinical eligibility of patients to successful transplant outcomes.
- Published
- 2024
- Full Text
- View/download PDF
4. Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions
- Author
-
Iyer, Sai Prasad N., Pino, Christopher J., Yessayan, Lenar T., Goldstein, Stuart L., Weir, Matthew R., Westover, Angela J., Catanzaro, David A., Chung, Kevin K., and Humes, H. David
- Published
- 2024
- Full Text
- View/download PDF
5. EggCountAI: a convolutional neural network-based software for counting of Aedes aegypti mosquito eggs
- Author
-
Javed, Nouman, López-Denman, Adam J., Paradkar, Prasad N., and Bhatti, Asim
- Published
- 2023
- Full Text
- View/download PDF
6. Holobiont perspectives on tripartite interactions among microbiota, mosquitoes, and pathogens
- Author
-
Zheng, Ronger, Wang, Qiqi, Wu, Runbiao, Paradkar, Prasad N., Hoffmann, Ary A., and Wang, Guan-Hong
- Published
- 2023
- Full Text
- View/download PDF
7. EggCountAI: a convolutional neural network-based software for counting of Aedes aegypti mosquito eggs
- Author
-
Nouman Javed, Adam J. López-Denman, Prasad N. Paradkar, and Asim Bhatti
- Subjects
Fecundity ,Artificial intelligence ,Mask RCNN ,Egg counting ,EggCountAI ,ICount ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Mosquito-borne diseases exert a huge impact on both animal and human populations, posing substantial health risks. The behavioural and fitness traits of mosquitoes, such as locomotion and fecundity, are crucial factors that influence the spread of diseases. In existing egg-counting tools, each image requires separate processing with adjustments to various parameters such as intensity threshold and egg area size. Furthermore, accuracy decreases significantly when dealing with clustered or overlapping eggs. To overcome these issues, we have developed EggCountAI, a Mask Region-based Convolutional Neural Network (RCNN)-based free automatic egg-counting tool for Aedes aegypti mosquitoes. Methods The study design involves developing EggCountAI for counting mosquito eggs and comparing its performance with two commonly employed tools—ICount and MECVision—using 10 microscopic and 10 macroscopic images of eggs laid by females on a paper strip. The results were validated through manual egg counting on the strips using ImageJ software. Two different models were trained on macroscopic and microscopic images to enhance egg detection accuracy, achieving mean average precision, mean average recall, and F1-scores of 0.92, 0.90, and 0.91 for the microscopic model, and 0.91, 0.90, and 0.90 for the macroscopic model, respectively. EggCountAI automatically counts eggs in a folder containing egg strip images, offering adaptable filtration for handling impurities of varying sizes. Results The results obtained from EggCountAI highlight its remarkable performance, achieving overall accuracy of 98.88% for micro images and 96.06% for macro images. EggCountAI significantly outperformed ICount and MECVision, with ICount achieving 81.71% accuracy for micro images and 82.22% for macro images, while MECVision achieved 68.01% accuracy for micro images and 51.71% for macro images. EggCountAI also excelled in other statistical parameters, with mean absolute error of 1.90 eggs for micro, 74.30 eggs for macro, and a strong correlation and R-squared value (0.99) for both micro and macro. The superior performance of EggCountAI was most evident when handling overlapping or clustered eggs. Conclusion Accurate detection and counting of mosquito eggs enables the identification of preferred egg-laying sites and facilitates optimal placement of oviposition traps, enhancing targeted vector control efforts and disease transmission prevention. In future research, the tool holds the potential to extend its application to monitor mosquito feeding preferences. Graphical Abstract
- Published
- 2023
- Full Text
- View/download PDF
8. Culex-Transmitted Diseases: Mechanisms, Impact, and Future Control Strategies using Wolbachia
- Author
-
Mukund Madhav, Kim R. Blasdell, Brendan Trewin, Prasad N. Paradkar, and Adam J. López-Denman
- Subjects
Culex ,Wolbachia ,arboviruses ,mosquito control ,Microbiology ,QR1-502 - Abstract
Mosquitoes of the Culex genus are responsible for a large burden of zoonotic virus transmission globally. Collectively, they play a significant role in the transmission of medically significant diseases such as Japanese encephalitis virus and West Nile virus. Climate change, global trade, habitat transformation and increased urbanisation are leading to the establishment of Culex mosquitoes in new geographical regions. These novel mosquito incursions are intensifying concerns about the emergence of Culex-transmitted diseases and outbreaks in previously unaffected areas. New mosquito control methods are currently being developed and deployed globally. Understanding the complex interaction between pathogens and mosquitoes is essential for developing new control strategies for Culex species mosquitoes. This article reviews the role of Culex mosquitos as vectors of zoonotic disease, discussing the transmission of viruses across different species, and the potential use of Wolbachia technologies to control disease spread. By leveraging the insights gained from recent successful field trials of Wolbachia against Aedes-borne diseases, we comprehensively discuss the feasibility of using this technique to control Culex mosquitoes and the potential for the development of next generational Wolbachia-based control methods.
- Published
- 2024
- Full Text
- View/download PDF
9. Electrochemical-based studies of Cu2SnSe3 nanocrystals and P3HT:PCBM for hybrid solar cells
- Author
-
Dwivedi, Shailendra Kumar, Tiwari, D C, Kumar, Neeraj, Tripathi, Santosh K, and Prasad, N Eswara
- Published
- 2023
- Full Text
- View/download PDF
10. Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ Failure
- Author
-
H. David Humes, MD, Stuart L. Goldstein, MD, Lenar T. Yessayan, MD, David A. Catanzaro, PharmD, Emily C. Scribe, PharmD, Sai Prasad N. Iyer, PhD, and Kevin K. Chung, MD
- Subjects
Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
OBJECTIVES:. Acute kidney injury (AKI) requiring continuous kidney replacement therapy is a significant complication in ICU patients with mortality rates exceeding 50%. A dysregulated immune response can lead to systemic inflammation caused by hyperactivity of pro-inflammatory neutrophils and monocytes leading to tissue damage. The selective cytopheretic device (SCD) is an investigational medical device in a new class of cell-directed extracorporeal therapies distinct from cytokine adsorbers or filters, as it targets activated leukocytes. These leukocytes are the cellular sources driving this hyperinflammatory process. The objective of this report is to summarize the safety experience from clinical studies of the SCD in ICU patients with AKI or acute respiratory distress syndrome (ARDS) and multiple organ dysfunction (MOD). DATA SOURCES AND STUDY SELECTION:. The studies included in this report represent all relevant trials of the SCD conducted in patients with AKI or ARDS and MOD. Adverse event data, clinical laboratory data and mortality rates were described and summarized in this report. DATA EXTRACTION AND DATA SYNTHESIS:. Five clinical studies were included in this report, including four adult studies of AKI and/or ARDS and one pediatric AKI study, which involved 151 patients treated with the SCD in an ICU setting. Over 800 SCD sessions were deployed with an estimated 19,000 exposure hours with no device-related infections or attributable serious adverse events. Furthermore, there were no safety signals of leukopenia, thrombocytopenia, or other indications of immunodepletion or immunosuppression. CONCLUSIONS:. The SCD has shown to be a promising extracorporeal therapy with promising clinical results and a favorable safety profile. These studies support that the SCD can be added as a therapeutic intervention in critically ill AKI patient populations with multiple organ failure without adding additional safety risks.
- Published
- 2023
- Full Text
- View/download PDF
11. Structural integrity and sealing behaviour of bolted flange joint: A state of art review
- Author
-
Nelson, N. Rino, Prasad, N Siva, and Sekhar, A.S.
- Published
- 2023
- Full Text
- View/download PDF
12. Electrical and magnetic studies on promising Aurivillius intergrowth compound
- Author
-
Veenachary, Vadla, Puli, Venkata Sreenivas, Babu, S. Narendra, Prasad, G., and Prasad, N. V.
- Published
- 2022
- Full Text
- View/download PDF
13. Seabed influence on wave scattering by a porous flexible barrier in a two-layer oblique sea
- Author
-
Prasad, N. M. and Prasad, R. M.
- Published
- 2022
- Full Text
- View/download PDF
14. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
- Author
-
Yadav, Priya, Ambudkar, Suresh V., and Rajendra Prasad, N.
- Published
- 2022
- Full Text
- View/download PDF
15. Development of milled carbon fibre-based GFRP composites and their effect on microwave and structural properties
- Author
-
Mishra, Shubham, Dubey, Ashish, Agarwal, Sanjay, Dixit, Alok K, and Prasad, N Eswara
- Published
- 2022
- Full Text
- View/download PDF
16. Biological activities of chitosan-salicylaldehyde schiff base assisted silver nanoparticles
- Author
-
Alharthi, Salman S., Gomathi, Thandapani, Joseph, J. John, Rakshavi, J., Florence, J. Annie Kamala, Sudha, Prasad N., Rajakumar, Govindasamy, and Thiruvengadam, Muthu
- Published
- 2022
- Full Text
- View/download PDF
17. Redox status and metabolomic profiling of thioredoxin reductase inhibitors and 4 kGy ionizing radiation-exposed Deinococcus radiodurans
- Author
-
Sudharsan, M., Prasad, N. Rajendra, Kanimozhi, G., Rishiikeshwer, B.S., Brindha, G.R., and Chakraborty, Anindita
- Published
- 2022
- Full Text
- View/download PDF
18. Developing Wolbachia-based disease interventions for an extreme environment.
- Author
-
Perran A Ross, Samia Elfekih, Sophie Collier, Melissa J Klein, Su Shyan Lee, Michael Dunn, Sarah Jackson, Yexin Zhang, Jason K Axford, Xinyue Gu, Jessica L Home, Majed S Nassar, Prasad N Paradkar, Essam A Tawfik, Francis M Jiggins, Abdulaziz M Almalik, Mohamed B Al-Fageeh, and Ary A Hoffmann
- Subjects
Immunologic diseases. Allergy ,RC581-607 ,Biology (General) ,QH301-705.5 - Abstract
Aedes aegypti mosquitoes carrying self-spreading, virus-blocking Wolbachia bacteria are being deployed to suppress dengue transmission. However, there are challenges in applying this technology in extreme environments. We introduced two Wolbachia strains into Ae. aegypti from Saudi Arabia for a release program in the hot coastal city of Jeddah. Wolbachia reduced infection and dissemination of dengue virus (DENV2) in Saudi Arabian mosquitoes and showed complete maternal transmission and cytoplasmic incompatibility. Wolbachia reduced egg hatch under a range of environmental conditions, with the Wolbachia strains showing differential thermal stability. Wolbachia effects were similar across mosquito genetic backgrounds but we found evidence of local adaptation, with Saudi Arabian mosquitoes having lower egg viability but higher adult desiccation tolerance than Australian mosquitoes. Genetic background effects will influence Wolbachia invasion dynamics, reinforcing the need to use local genotypes for mosquito release programs, particularly in extreme environments like Jeddah. Our comprehensive characterization of Wolbachia strains provides a foundation for Wolbachia-based disease interventions in harsh climates.
- Published
- 2023
- Full Text
- View/download PDF
19. CFD modeling and optimal design of SiC deposition on the fuel combustion nozzle in a commercial CVD reactor
- Author
-
Bijjargi, Yogesh S., Shinde, Vijay M., Mudgal, Abhisek, Kumar, Harish, and Prasad, N Eswara
- Published
- 2022
- Full Text
- View/download PDF
20. Contactless monitoring of respiratory rate (RR) and heart rate (HR) in non-acuity settings: a clinical validity study
- Author
-
Muralidhar Varma, Manikanda Krishnan Vaidyanathan, Joseph Thomas, Trevor Sequeira, Navaneetha Krishnan S Naidu, Yogish Mallya, Amarendranath Sunkara, Praveen Patil, Nagaraj Poojary, Benoît Balmaekers, Shankar Prasad N, and Sulochana Badagabettu
- Subjects
Medicine - Abstract
Objective Patient monitoring in general wards primarily involves intermittent observation of temperature, heart rate (HR), respiratory rate (RR) and blood pressure performed by the nursing staff. Several hours can lapse between such measurements, and the patient may go unobserved. Despite the growing widespread use of sensors to monitor vital signs and physical activities of healthy individuals, most acutely ill hospitalised patients remain unmonitored, leaving them at an increased risk. We investigated whether a contactless monitoring system could measure vital parameters, such as HR and RR, in a real-world hospital setting.Design A cross-sectional prospective study.Setting and participants We examined the suitability of employing a non-contact monitoring system in a low-acuity setup at a tertiary care hospital in India. Measurements were performed on 158 subjects, with data acquired through contactless monitoring from the general ward and dialysis unit.Outcome measures Vital parameters (RR and HR) were measured using a video camera in a non-acuity setting.Results Three distinct combinations of contactless monitoring afforded excellent accuracy. Contactless RR monitoring was linearly correlated with Alice NightOne and manual counts, presenting coefficients of determination of 0.88 and 0.90, respectively. Contactless HR monitoring presented a coefficient of determination of 0.91. The mean absolute errors were 0.84 and 2.15 beats per minute for RR and HR, respectively.Conclusions Compared with existing Food and Drug Administration-approved monitors, the findings of the present study revealed that contactless monitoring of RR and HR accurately represented study populations in non-acuity settings. Contactless video monitoring is an unobtrusive and dependable method for monitoring and recording RR and HR. Further research is needed to validate its dependability and utility in other settings, including acute care.Trial registration number CTRI/2018/11/016246.
- Published
- 2022
- Full Text
- View/download PDF
21. A systematic review of randomized controlled trials on survival rate of atraumatic restorative treatment compared with conventional treatment on primary dentition
- Author
-
Harsha G Chaudhari, Raju U Patil, Prasad N Jathar, and Chirayu A Jain
- Subjects
atraumatic restorative treatment ,conventional restorative treatments ,deciduous teeth ,or primary teeth ,Dentistry ,RK1-715 - Abstract
Background: In this COVID era, it's critical to promote nonaerosol procedures. Atraumatic restorative treatment (ART) is one of them, and it's particularly effective in children for lowering anxiety, enhancing dental health, and giving restorative care. Aim: The aim of this study was to assess the survival rate of ART compared with conventional treatment procedures in primary dentition. Materials and Methods: The review was done in accordance with the Preferred Reporting Items for Systematic reviews and Meta-analysis statement and is been registered in PROSPERO (CRD42021213729). The studies included comprised clinical investigations with randomized controlled trials (RCTs) which compared the survival rate of ART and conventional restorative treatments using the same or different restorative materials to treat carious lesion. RCTs in which ART was compared with conventional treatment on patients in the age group of 6–10 years with minimum follow-up of 6 months. Studies available as open access and free full text in PubMed, DOAJ, and Google Scholar databases, and published in English Language only were included in the study. Cochrane's collaboration tool for RCTs was used for the assessment of risk of bias. Results: The survival rate of single surface and multiple surface in primary dentition treated according to the ART compared with conventional treatment was found to be similar. Conclusion: The ART approach is equally helpful in managing dental caries in children and this method may be considered a useful intervention in clinical practice to enhance the dental health of children.
- Published
- 2022
- Full Text
- View/download PDF
22. Residual solvent induced physical morphology and gas permeation in polyamide-imide membrane: Experimental investigation and molecular simulations
- Author
-
Shiva Prasad, N., Babarao, Ravichandar, Madapusi, Srinivasan, Sridhar, Sundergopal, Choudhury, Namita Roy, and Bhargava, Suresh K.
- Published
- 2022
- Full Text
- View/download PDF
23. Stable 3D hierarchical scaffolds by origami approach: Effect of interfacial crosslinking by nanohybrid shish-kebab assemblies
- Author
-
Prabhakar, Shanu, Singh, Jitendra Pratap, Roy, Debmalya, and Prasad, N. Eswara
- Published
- 2022
- Full Text
- View/download PDF
24. Solar energy EV charging system using integrated Zeta-Luo converter.
- Author
-
Kancherla, Ananda Babu, Prasad, N. Bhanu, and Kishore, D. Ravi
- Subjects
ELECTRIC vehicle charging stations ,SOLAR energy ,ELECTRIC vehicles ,PHOTOVOLTAIC power systems ,CITIES & towns ,LOW voltage systems - Abstract
This paper focuses on a grid-incorporated solar electric vehicle (EV) charging station that maximizes the acceptance of EVs in agricultural areas and reduces the over-reliance on the grid of urban cities. Since photovoltaic (PV) systems are widely available and easy to install, they are an excellent choice for EV charging applications. Hence, the aim of this work is to combine PV and EV, in order to achieve the objectives of both decarbonized energy generation and transportation. A Modified Zeta Integrated Luo Converter (MZILC), which provides a large conversion range combined with lower voltage stress, is proposed intending to increase the voltage level of the PV system. Furthermore, the converter generates a stable output devoid of fluctuations with the usage of the Grey Wolf–Grasshopper Optimized Proportional Integral (GW-GOPI) controller. Electricity for BLDC motors is generated by PV power during the day and supplied by a single-phase grid at night. The efficiency of the suggested grid-connected PV-based EV charging station is examined in MATLAB environment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Culex -Transmitted Diseases: Mechanisms, Impact, and Future Control Strategies using Wolbachia.
- Author
-
Madhav, Mukund, Blasdell, Kim R., Trewin, Brendan, Paradkar, Prasad N., and López-Denman, Adam J.
- Subjects
WEST Nile fever ,JAPANESE encephalitis viruses ,WEST Nile virus ,MOSQUITO-borne diseases ,CULEX ,MOSQUITO control - Abstract
Mosquitoes of the Culex genus are responsible for a large burden of zoonotic virus transmission globally. Collectively, they play a significant role in the transmission of medically significant diseases such as Japanese encephalitis virus and West Nile virus. Climate change, global trade, habitat transformation and increased urbanisation are leading to the establishment of Culex mosquitoes in new geographical regions. These novel mosquito incursions are intensifying concerns about the emergence of Culex-transmitted diseases and outbreaks in previously unaffected areas. New mosquito control methods are currently being developed and deployed globally. Understanding the complex interaction between pathogens and mosquitoes is essential for developing new control strategies for Culex species mosquitoes. This article reviews the role of Culex mosquitos as vectors of zoonotic disease, discussing the transmission of viruses across different species, and the potential use of Wolbachia technologies to control disease spread. By leveraging the insights gained from recent successful field trials of Wolbachia against Aedes-borne diseases, we comprehensively discuss the feasibility of using this technique to control Culex mosquitoes and the potential for the development of next generational Wolbachia-based control methods. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Structural and microwave properties of Ag-doped strontium hexaferrite
- Author
-
Maramu, Nyathani, Ravinder, D., Anil Babu, T., Srinivas, M., Ravinder Reddy, B., Sriramulu, G., Sadhana, Katlakuntla, and Krishna Prasad, N. V.
- Published
- 2021
- Full Text
- View/download PDF
27. Biological activities of chitosan-salicylaldehyde schiff base assisted silver nanoparticles
- Author
-
Salman S. Alharthi, Thandapani Gomathi, J. John Joseph, J. Rakshavi, J. Annie Kamala Florence, Prasad N. Sudha, Govindasamy Rajakumar, and Muthu Thiruvengadam
- Subjects
Silver nanoparticles ,Chitosan ,Schiff base ,Salicylaldehyde ,Biological assay ,Biosafety assay ,Science (General) ,Q1-390 - Abstract
Objectives: The nanobiotechnology era has sparked interest in the green synthesis of stable silver nanoparticles (Ag-NPs) without hazardous chemicals. As a result, the current study used chitosan-salicylaldehyde Schiff base (CSB) as a non-toxic, reducing and stabilizing agent to prepare stable silver nanoparticles. Methods: The characterization of Ag-NPs impregnated chitosan-salicylaldehyde Schiff base was fulfilled using UV-Vis, FTIR, XRD and TEM studies. Results: The absorption band present around 425 nm in UV-Vis spectra indicated the formation of Ag-NPs. The appearance of a new band for the CN bond, deduction in the intensity of the CO group of salicylaldehyde and NH group of chitosan confirmed the formation of Schiff base and Ag-NPs in FTIR analysis. XRD pattern revealed the orientation and crystalline nature of Ag-NPs with 2θ at 38°, 46° and 54° related to Ag-NPs (JCPDS No. 04-0783), whereas the peak at 2θ = 27° associated with CSB. The total porosity of 53.24% was determined using the liquid displacement method. The CSB-Ag-NPs have good scavenging activity (46.25% and 49.35% activity in DPPH assay and H2O2 assay), great antibacterial (zone of inhibition 17 mm and 19 mm for E-Coli and Pseudomonas sp.), antifungal (18 mm for P. notatum), and anti-larvicidal activity, according to biological assessments. Conclusions: The synthesised Ag-NPs were non-toxic to marine ecosystems in a safety bioassay test.
- Published
- 2022
- Full Text
- View/download PDF
28. Magnetoelectric Properties of Aurivillius-Layered Perovskites.
- Author
-
Veenachary, Vadla, Ramana, Eskilla Venkata, Narendra Babu, Simhachalam, Puli, Venkata Sreenivas, Saha, Sujoy, Srinivasan, Gopalan, Prasad, G., and Prasad, N. V.
- Subjects
PEROVSKITE ,RARE earth ions ,MAGNETIC ions ,PHASE transitions ,MAGNETIC hysteresis ,POLARONS ,RARE earth oxides ,SAMARIUM - Abstract
In the present work, we have synthesized rare-earth ion modified Bi
4−x REx Ti2 Fe0.7 Co0.3 O12−δ (RE = Dy, Sm, La) multiferroic compounds by the conventional solid-state route. Analysis of X-ray diffraction by Rietveld refinement confirmed the formation of a polycrystalline orthorhombic phase. The morphological features revealed a non-uniform, randomly oriented, plate-like grain structure. The peaks evident in the Raman spectra closely corresponded to those of orthorhombic Aurivillius phases. Dielectric studies and impedance measurements were carried out. Asymmetric complex impedance spectra suggested the relaxation of charge carriers belonging to the non-Debye type and controlled by a thermally activated process. Temperature-dependent AC conductivity data showed a change of slope in the vicinity of the phase transition temperature of both magnetic and electrical coupling natures. Based on the universal law and its exponent nature, one can suppose that the conduction process is governed by a small polaron hopping mechanism but significant distortion of TiO6 octahedral. The doping of the A-sites with rare-earth element ions and changes in the concentrations of Fe and Co ions located on the B-sites manifested themselves in saturated magnetic hysteresis loops, indicating competitive interactions between ferroelectric and canted antiferromagnetic spins. The magnetic order in the samples is attributed to pair-wise interactions between adjacent Fe3+ –O–Fe3+ , Co2+/3+ –O–Co3+/2+ , and Co2+/3+ –O–Fe3+ ions or Dzyaloshinskii–Moriya interactions among magnetic ions in the adjacent sub-lattices. As a result, enhanced magnetoelectric coefficients of 42.4 mV/cm-Oe, 30.3 mV/cm-Oe, and 21.6 mV/cm-Oe for Bi4−x Dyx Ti2 Fe0.7 Co0.3 O12−δ (DBTFC), Bi4−x Lax Ti2 Fe0.7 Co0.3 O12−δ (LBTFC), and Bi4−x Smx Ti2 Fe0.7 Co0.3 O12−δ (SBTFC), respectively, have been obtained at lower magnetic fields (<3 kOe). The strong coupling of the Aurivillius compounds observed in this study is beneficial to future multiferroic applications. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
29. Effect of Cold Adaptation on the State of Cardiovascular System and Cardiac Tolerance to Ischemia/Reperfusion Injury.
- Author
-
Voronkov, Nikita S., Popov, Sergey V., Naryzhnaya, Natalia V., Prasad, N. Rajendra, Petrov, Ivan M., Kolpakov, Viktor V., Tomilova, Evgenia A., Sapozhenkova, Ekaterina V., and Maslov, Leonid N.
- Published
- 2024
- Full Text
- View/download PDF
30. Retraction Note: Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines
- Author
-
Mohana, S., Ganesan, M., Rajendra Prasad, N., Ananthakrishnan, D., and Velmurugan, D.
- Published
- 2021
- Full Text
- View/download PDF
31. Utility of long-read sequencing for All of Us.
- Author
-
Mahmoud, M., Huang, Y., Garimella, K., Audano, P. A., Wan, W., Prasad, N., Handsaker, R. E., Hall, S., Pionzio, A., Schatz, M. C., Talkowski, M. E., Eichler, E. E., Levy, S. E., and Sedlazeck, F. J.
- Subjects
NUCLEOTIDE sequencing ,COHORT analysis ,GENOMES - Abstract
The All of Us (AoU) initiative aims to sequence the genomes of over one million Americans from diverse ethnic backgrounds to improve personalized medical care. In a recent technical pilot, we compare the performance of traditional short-read sequencing with long-read sequencing in a small cohort of samples from the HapMap project and two AoU control samples representing eight datasets. Our analysis reveals substantial differences in the ability of these technologies to accurately sequence complex medically relevant genes, particularly in terms of gene coverage and pathogenic variant identification. We also consider the advantages and challenges of using low coverage sequencing to increase sample numbers in large cohort analysis. Our results show that HiFi reads produce the most accurate results for both small and large variants. Further, we present a cloud-based pipeline to optimize SNV, indel and SV calling at scale for long-reads analysis. These results lead to widespread improvements across AoU. Using All of Us pilot data, the authors compared short- and long-read performance across medically relevant genes and showcased the utility of long reads to improve variant detection and phasing in easy and hard to resolve medically relevant genes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. SrHfO3:Cr3+ Perovskite Microcubes for Rare-Earth-Free NIR-I Light Emission.
- Author
-
Gupta, Santosh K., Balhara, Annu, Shaw, S. K., Prasad, N. K., and Sudarshan, K.
- Subjects
CRYSTALLINE electric field ,X-ray photoelectron spectroscopy ,PEROVSKITE ,POSITRON annihilation ,CHROMIUM ions ,NEAR infrared radiation ,VIDEO surveillance - Abstract
Near-infrared (NIR)-emitting phosphors are in high demand owing to their application in areas of high importance, such as security, night-surveillance, imaging, storage, and optoelectronics. However, to achieve high success in these applications, wide broadband NIR emissions are needed and, in that context, the crystalline field of the host matrix plays a very important role. In this work, we have achieved a broad NIR emission in the range of 700–1000 nm in hydrothermally synthesized SrHfO
3 :Cr3+ (SHOC). SHO assumes a microcrystalline cube morphology, and chromium doping make it more and more symmetric, and the particle size increases with doping. Broadband NIR emissions have been ascribed to the stabilization of Cr3+ in a strong crystalline field of HfO6 octahedra. X-ray photoelectron spectroscopy supported this by confirming the formation of oxygen vacancies in all the samples. The shorter lifetime (~13–44 µs) is attributed to chromium ions situated in close vicinity to oxygen vacancies at distance X, whereas the longer-lived (~56–127 µs) originate from chromium ions situated at a long distance from oxygen vacancies at distance Y, and Y is greater than X. Positron annihilation lifetime spectroscopy suggested an increase in defect concentration with doping, which causes concentration quenching beyond 2.0 mol% endowed by multipolar interactions. This work culminates the very important role of defects, local site, and doping on efficient NIR light emissions from a perovskite lattice. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
33. MXenes-Based Supercapacitors: A Review on Energy Storage Devices.
- Author
-
Krishna Prasad, N. V. and Madhavi, N.
- Subjects
ENERGY storage ,ENERGY density ,ELECTRODE potential ,STORAGE batteries ,SYSTEMS software ,SUPERCAPACITORS - Abstract
Energy storage and energy-storage devices have been a buzzword for long time as it is one of the essential needs in human life. These devices include mechanical systems, thermal systems, and batteries. These systems embedded with software can monitor the charging and discharging phenomena of energy. In this context, the role of rechargeable batteries needs to be reviewed. Even though novel types of rechargeable batteries are being continuously developed for storage of electricity, more attention and research towards supercapacitors is on the way. Huge number of researchers around the globe is involved in developing supercapacitors with improved performance making them more and more useful. The main aim is to improve their efficiency, energy density, operating voltage, miniaturization, optimization, economy, and environmental acceptance. For the last few years, lightweight and carbon-based novel wearable supercapacitors are developed. High durability, eco-friendliness, being non-volatile and electrostatic mechanism of supercapacitors make them advantageous than conventional batteries. In this regard, advances in microelectronics demand microsupercapacitors (MSCs). The selection of electrode in microsupercapacitor plays significant role in the fabrication. In this selection, MXenes as a family of 2D material play a vital role. Very high conductivity and high capacity of charge storage makes MXenes as one of the potential materials for electrodes in microsupercapacitors. This prompts us to review the role of MXenes in microsupercapacitors. This article reviews the recent advances of MXenes-based MSCs with emphasis on their fabrication techniques. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Metamaterial Sensors in Liquid Detection: An Illustrious Review.
- Author
-
Krishna Prasad, N. V. and Madhavi, N.
- Subjects
CLOAKING devices ,WATER purification ,SALINE water conversion ,METAMATERIALS ,REVERSE osmosis ,FINITE integration technique ,DETECTORS - Abstract
Liquid detection has been one of the buzzwords that refer to sensing of various liquids, which include water, chemicals, oils, etc. This detection gains more significance with the advent of metamaterials. Metamaterials are proved well suited in antenna designing, cloaking devices, solar cells, and sensors. Many papers reported metamaterial sensors, which can detect liquid chemicals, oils, etc. through shift in resonance frequency. Very few papers reported the applications of metamaterial sensors in water treatment. Water purification is one of the prime essentials for the existence of healthy humankind. It can be used to remove unwanted chemicals, contaminants and gases from water. The process of water purification can be done with various methods such as thermal, adsorption, distillation, desalination, reverse osmosis, etc. The main aim is to produce water required for specific purpose. In this context, role of metamaterials in water purification is of prime significance. Keeping this in view, an attempt is made to review the importance of metamaterial sensors in liquid detection along with water purification and its importance in comparison with earlier techniques already available. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. New opportunity for targeting systemic inflammation in patients with heart failure through leucocyte immunomodulation.
- Author
-
Pitt, Bertram, Iyer, Sai Prasad N., and Humes, H. David
- Subjects
- *
HEART failure , *HEART failure patients , *LEUCOCYTES , *INFLAMMATION , *SHORT-chain fatty acids , *IMMUNOREGULATION - Abstract
The article discusses the potential for targeting systemic inflammation in patients with heart failure through leucocyte immunomodulation. It highlights the high incidence of cardiovascular mortality and hospitalizations for heart failure despite current therapies. The role of inflammation in heart failure is explored, with a focus on the involvement of proinflammatory cytokines and biomarkers. The article introduces a novel approach using a selective cytopheretic device (SCD) to target activated neutrophils and monocytes, which has shown promise in reducing systemic inflammation and improving outcomes in other acute conditions. A case report is presented to demonstrate the potential effectiveness of the SCD in bridging patients to left ventricular assist device (LVAD) implantation. The article concludes by suggesting that further studies are needed to evaluate the use of the SCD and its potential to reduce cardiovascular mortality and hospitalizations in heart failure patients. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
36. Towards Integrated Management of Dengue in Mumbai
- Author
-
Prasad N. Paradkar, Pallavi R. Sahasrabudhe, Mrunal Ghag Sawant, Sandeepan Mukherjee, and Kim R. Blasdell
- Subjects
dengue ,mosquito ,India ,Mumbai ,novel strategies ,Wolbachia ,Microbiology ,QR1-502 - Abstract
With increasing urbanisation, the dengue disease burden is on the rise in India, especially in large cities such as Mumbai. Current dengue surveillance in Mumbai includes municipal corporation carrying out specific activities to reduce mosquito breeding sites and the use of insecticides to suppress the adult mosquito populations. Clinical cases remain either underreported or misreported due to the restriction to government clinics, missing the large private health care sector. There is a need for an integrated approach to manage dengue outbreaks in Mumbai. There are various novel strategies available for use that can be utilised to improve disease detection, mosquito surveillance, and control of mosquito-borne diseases. These novel technologies are discussed in this manuscript. Given the complex ecosystem of mosquito-borne diseases in Mumbai, integrating data obtained from these technologies would support the ongoing mosquito control measures in Mumbai.
- Published
- 2021
- Full Text
- View/download PDF
37. Advances in Understanding Vector Behavioural Traits after Infection
- Author
-
Nouman Javed, Asim Bhatti, and Prasad N. Paradkar
- Subjects
vector-borne diseases ,vector behaviour ,mosquito ,ticks ,Medicine - Abstract
Vector behavioural traits, such as fitness, host-seeking, and host-feeding, are key determinants of vectorial capacity, pathogen transmission, and epidemiology of the vector-borne disease. Several studies have shown that infection with pathogens can alter these behavioural traits of the arthropod vector. Here, we review relevant publications to assess how pathogens modulate the behaviour of mosquitoes and ticks, major vectors for human diseases. The research has shown that infection with pathogens alter the mosquito’s flight activity, mating, fecundity, host-seeking, blood-feeding, and adaptations to insecticide bed nets, and similarly modify the tick’s locomotion, questing heights, vertical and horizontal walks, tendency to overcome obstacles, and host-seeking ability. Although some of these behavioural changes may theoretically increase transmission potential of the pathogens, their effect on the disease epidemiology remains to be verified. This study will not only help in understanding virus–vector interactions but will also benefit in establishing role of these behavioural changes in improved epidemiological models and in devising new vector management strategies.
- Published
- 2021
- Full Text
- View/download PDF
38. Rapidly Progressive Renal Failure in Type 2 Diabetic versus Non-diabetic Patients: Changing Trends, Natural History, and Outcome in an Indian Tertiary Care Center.
- Author
-
Chandrashekhar, Praveen, Kaul, Anupma, Bhaduaria, Dharmendra, Prasad, N., Jain, M., Patel, M., and Gupta, A.
- Published
- 2023
39. Applications of 2D Materials (MXenes) in Sensors: A Minireview.
- Author
-
Krishna Prasad, N. V. and Madhavi, N.
- Subjects
ELECTROMAGNETIC shielding ,IONIC conductivity ,DETECTORS ,WEARABLE technology ,COMPOSITE materials - Abstract
MXenes are a class of 2D material produced from the MAX phase structure, e.g., 3D atomic laminate Ti
3 AlC2 ; they have a combination of layered carbides and nitrides. They belong to a distinctive type of structured materials with better conductivity than metals, increased ionic conductivity, flexible mechanical properties, and being hydrophilic. MXenes can be structured to form nanoparticles, multi- and single-layered nanosheets, which exhibit large specific surface areas enhancing their efficiency of sensing in MXene sensors. In addition, they are capable of forming composites with other materials with ease. Their morphology enhances their mechanical flexibility and stretchability enabling them to have wide applications in energy-storage devices, wearable sensors, and for electromagnetic shielding. Considering this, an attempt is made to review the recent advances in MXenes with emphasis on their applications in the area of wearable sensors that include pressure, strain, biochemical, temperature and gas sensing. [ABSTRACT FROM AUTHOR]- Published
- 2023
40. Electrochemical-based studies of Cu2SnSe3 nanocrystals and P3HT:PCBM for hybrid solar cells.
- Author
-
Dwivedi, Shailendra Kumar, Tiwari, D C, Kumar, Neeraj, Tripathi, Santosh K, and Prasad, N Eswara
- Abstract
In this work, we have fabricated hybrid heterojunction solar cells with structure ITO/ZnO/P3HT:PCBM:CTSe NCs (optimized weight percentage 10 wt%)/MoO
3 /Ag (device SM10). A thin layer of molybdenum oxide MoO3 prepared by peroxomolybdic acid organosol as the precursor was used as hole transport layers (HTLs). The performance of the device was compared with ITO/ZnO/P3HT:PCBM:CTSe NCs/Ag(device S10). The important parameters such as global charge carrier mobility (µ), effective charge carriers lifetime (τn ) and charge diffusion time (τd ) have been extracted from electrochemical impedance spectroscopy (EIS) performed at the bias of 0.1 V in the dark. The Nyquist plot obtained from EIS has demonstrated effective carriers lifetime, global mobility and charge diffusion time for a device SM10 as 6.46 ms, 12.6 × 10−4 cm2 V−1 S−1 and 5.2 µs and for device S10 as 5.65 ms, 9.58 × 10−4 cm2 V−1 S−1 and 6.8 µs, respectively. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
41. Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis
- Author
-
Maher, TM, Ford, P, Brown, KK, Costabel, U, Cottin, V, Danoff, SK, Groenveld, I, Helmer, E, Jenkins, RG, Milner, J, Molenberghs, G, Penninckx, B, Randall, MJ, Van Den Blink, B, Fieuw, A, Vandenrijn, C, Rocak, S, Seghers, I, Shao, L, Taneja, A, Jentsch, G, Watkins, TR, Wuyts, WA, Kreuter, M, Verbruggen, N, Prasad, N, Wijsenbeek, MS, Chambers, D, Chia, M, Corte, T, Glaspole, I, Goh, N, Holmes, M, Malouf, M, Thien, F, Veitch, E, Bondue, B, Dahlqvist, C, Froidure, A, Slabbynck, H, Wuyts, W, Cartagena Salinas, C, Feijoó Seoane, R, Martínez, V, Maturana, R, Pavie Gallegos, J, Rosenblut, A, Silva, R, Undurraga Pereira, A, Doubkova, M, Pauk, N, Plackova, M, Sterclova, M, Bendstrup, E, Shaker, SB, Titlestad, I, Budweiser, S, Grohé, C, Koschel, D, Prasse, A, Weber, M, Wirtz, H, Antoniou, K, Daniil, Z, Gaga, M, Papakosta, D, Izumi, S, Okamoto, M, Guerreros Benavides, A, Iberico Barrera, C, Peña Villalobos, AM, Campo Ezquibela, A, Cifrian Martinez, JM, Fernandez Fabrellas, E, Leiro, V, Molina-Molina, M, Nieto Barbero, A, Sellares Torres, J, Valenzuela, C, Cheng, S-L, Kuo, P-H, Lee, K-Y, Sheu, C-C, Gunen, H, Mogulkoc Bishop, N, Nayci, S, Adamali, H, Bianchi, S, Chaudhuri, N, Gibbons, M, Hart, S, Molyneaux, P, Parfrey, H, Saini, G, Spencer, LG, Wiscombe, S, Antin-Ozerkis, D, Bascom, R, Belperio, J, Britt, E, Fitzgerald, J, Gomez Manjarres, D, Gotfried, M, Gupta, N, Hotchkin, D, Kaye, M, Kreider, M, Kureishy, S, Lacamera, P, Lancaster, L, Lasky, J, Lorch, D, Mannem, H, Morrow, L, Moua, T, Nambiar, A, Raghu, G, Raj, R, Ramaswamy, M, Reddy, R, Russell, T, Scholand, MB, Shea, B, Suliman, S, Swigris, J, Thavarajah, K, Tolle, L, Tomic, R, Warshoff, N, Wesselius, L, Yung, G, Bergna, M, De Salvo, M, Fernandez Acquier, M, Rodriguez, A, Saez Scherbovsky, P, Assayag, D, Dhar, A, Khalil, N, Morisset, J, Provencher, S, Ryerson, C, Shapera, S, Bourdin, A, Crestani, B, Lebargy, F, Reynaud-Gaubert, M, Bonella, FT, Claussen, M, Hammerl, P, Karagiannidis, C, Keller, C, Randerath, W, Stubbe, B, Csánky, E, Medgyasszay, B, Muller, V, Adir, Y, Bar-Shai, A, Berkman, N, Fink, G, Kramer, M, Shitrit, D, Bargagli, E, Gasparini, S, Harari, S, Ravaglia, C, Richeldi, L, Vancheri, C, Ebina, M, Fujita, M, Ichikado, K, Inoue, Y, Ishikawa, N, Kato, M, Kawamura, T, Kondoh, Y, Nishioka, Y, Ogura, T, Owan, I, Saito, T, Sakamoto, N, Sakamoto, K, Shirai, M, Suda, T, Tomii, K, Chung, MP, Jeong, SH, Park, CS, Park, JS, Song, JW, Uh, S-T, Chavarria Martinez, U, Montano Gonzalez, E, Ramirez, A, Selman Lama, ME, Bresser, P, Kramer, H, Mostard, R, Nossent, E, Veltkamp, M, Wijsenbeek, M, Beckert, L, Chang, CL, Veale, A, Wilsher, M, Bednarek, M, Gasior, G, Jasieniak-Pinis, G, Jassem, E, Mroz, R, Piotrowski, W, Abdullah, I, Ambaram, A, Irusen, E, Van der Linden, M, Van Zyl-Smit, R, Williams, P, Allen, J, Averill, F, Belloli, E, Brown, A, Case, A, Chaudhary, S, Criner, G, DeBoer, K, Dilling, D, Dorf, J, Enelow, R, Ettinger, N, Feldman, J, Gibson, K, Golden, J, Hamblin, M, Hunninghake, G, Karunakara, R, Kim, H, Luckhardt, T, Menon, P, Morrison, L, Oldham, J, Patel, N, Schmidt, S, Strek, M, Summer, R, Sussman, R, Tita, J, Veeraraghavan, S, Whelan, T, and Zibrak, J
- Abstract
Importance There is a major need for effective, well-tolerated treatments for idiopathic pulmonary fibrosis (IPF). Objective To assess the efficacy and safety of the autotaxin inhibitor ziritaxestat in patients with IPF. Design, Setting, and Participants The 2 identically designed, phase 3, randomized clinical trials, ISABELA 1 and ISABELA 2, were conducted in Africa, Asia-Pacific region, Europe, Latin America, the Middle East, and North America (26 countries). A total of 1306 patients with IPF were randomized (525 patients at 106 sites in ISABELA 1 and 781 patients at 121 sites in ISABELA 2). Enrollment began in November 2018 in both trials and follow-up was completed early due to study termination on April 12, 2021, for ISABELA 1 and on March 30, 2021, for ISABELA 2. Interventions Patients were randomized 1:1:1 to receive 600 mg of oral ziritaxestat, 200 mg of ziritaxestat, or placebo once daily in addition to local standard of care (pirfenidone, nintedanib, or neither) for at least 52 weeks. Main Outcomes and Measures The primary outcome was the annual rate of decline for forced vital capacity (FVC) at week 52. The key secondary outcomes were disease progression, time to first respiratory-related hospitalization, and change from baseline in St George’s Respiratory Questionnaire total score (range, 0 to 100; higher scores indicate poorer health-related quality of life). Results At the time of study termination, 525 patients were randomized in ISABELA 1 and 781 patients in ISABELA 2 (mean age: 70.0 [SD, 7.2] years in ISABELA 1 and 69.8 [SD, 7.1] years in ISABELA 2; male: 82.4% and 81.2%, respectively). The trials were terminated early after an independent data and safety monitoring committee concluded that the benefit to risk profile of ziritaxestat no longer supported their continuation. Ziritaxestat did not improve the annual rate of FVC decline vs placebo in either study. In ISABELA 1, the least-squares mean annual rate of FVC decline was –124.6 mL (95% CI, −178.0 to −71.2 mL) with 600 mg of ziritaxestat vs –147.3 mL (95% CI, −199.8 to −94.7 mL) with placebo (between-group difference, 22.7 mL [95% CI, −52.3 to 97.6 mL]), and –173.9 mL (95% CI, −225.7 to −122.2 mL) with 200 mg of ziritaxestat (between-group difference vs placebo, −26.7 mL [95% CI, −100.5 to 47.1 mL]). In ISABELA 2, the least-squares mean annual rate of FVC decline was –173.8 mL (95% CI, −209.2 to −138.4 mL) with 600 mg of ziritaxestat vs –176.6 mL (95% CI, −211.4 to −141.8 mL) with placebo (between-group difference, 2.8 mL [95% CI, −46.9 to 52.4 mL]) and –174.9 mL (95% CI, −209.5 to −140.2 mL) with 200 mg of ziritaxestat (between-group difference vs placebo, 1.7 mL [95% CI, −47.4 to 50.8 mL]). There was no benefit with ziritaxestat vs placebo for the key secondary outcomes. In ISABELA 1, all-cause mortality was 8.0% with 600 mg of ziritaxestat, 4.6% with 200 mg of ziritaxestat, and 6.3% with placebo; in ISABELA 2, it was 9.3% with 600 mg of ziritaxestat, 8.5% with 200 mg of ziritaxestat, and 4.7% with placebo. Conclusions and Relevance Ziritaxestat did not improve clinical outcomes compared with placebo in patients with IPF receiving standard of care treatment with pirfenidone or nintedanib or in those not receiving standard of care treatment. Trial Registration ClinicalTrials.gov Identifiers: NCT03711162 and NCT03733444
- Published
- 2023
42. The kinetic and mechanistic study of levetiracetam oxidation with chloramine-B in acid medium
- Author
-
null Kallesha N, null Prasad N, null Mahadeva Swamy M, and null Gnanendra C.R.
- Subjects
Pulmonary and Respiratory Medicine ,Pediatrics, Perinatology and Child Health ,Acid medium ,Levetiracetam ,Chloramine-B ,Kinetics ,Oxidation - Abstract
The medicine levetiracetam, marketed under the brand name Keppra, is approved by the Food and Drug Administration, used to treat seizures. It belongs to a class of drug known as anticonvulsants. The current work uses sodium-N-chloro-benzene sulfonamide or chloramine-B to evaluate the kinetics and mechanistic of levetiracetam at 308 K in HCl medium. (CAB). The reaction has a first-order dependence on [CAB]0and [substrate]0, as well as a fractional-order dependence on the concentration of [HCl]. Changes in ionic strength or the adding of benzene sulfonamide have no effect on the rate. We looked at the effect at five temperatures. The Arrhenius plots were used to evaluate the thermodynamic parameters. The reaction stoichiometry was found 1:2, and chromatographic and spectroscopic studies anticipated the oxidation product imine. The probable mechanism back up the above-mentioned findings. The relevant rate law has been determined because of all these discoveries.
- Published
- 2023
- Full Text
- View/download PDF
43. N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection
- Author
-
S. Sadia Ameen, Nane Griem-Krey, Antoine Dufour, M. Iqbal Hossain, Ashfaqul Hoque, Sharelle Sturgeon, Harshal Nandurkar, Dominik F. Draxler, Robert L. Medcalf, Mohd Aizuddin Kamaruddin, Isabelle S. Lucet, Michael G. Leeming, Dazhi Liu, Amardeep Dhillon, Jet Phey Lim, Faiza Basheer, Hong-Jian Zhu, Laita Bokhari, Carli L. Roulston, Prasad N. Paradkar, Oded Kleifeld, Andrew N. Clarkson, Petrine Wellendorph, Giuseppe D. Ciccotosto, Nicholas A. Williamson, Ching-Seng Ang, and Heung-Chin Cheng
- Subjects
Biochemistry & Molecular Biology ,Cells ,1.1 Normal biological development and functioning ,Glutamic Acid ,Biochemistry ,Analytical Chemistry ,Mice ,Underpinning research ,Genetics ,Animals ,2.1 Biological and endogenous factors ,CaM kinase IIa ,CaM kinase IIb ,Aetiology ,Molecular Biology ,Neurons ,Cultured ,Calpain ,Neurosciences ,neuronal death ,synaptic damage ,Rats ,Brain Disorders ,Stroke ,CRMP2 ,proteolytic processing ,Proteolysis ,Neurological ,neuroprotection ,Nervous System Diseases ,calpains ,excitotoxicity ,Src - Abstract
Excitotoxicity, a neuronal death process in neurological disorders such as stroke, is initiated by the overstimulation of ionotropic glutamate receptors. Although dysregulation of proteolytic signaling networks is critical for excitotoxicity, the identity of affected proteins and mechanisms by which they induce neuronal cell death remain unclear. To address this, we used quantitative N-terminomics to identify proteins modified by proteolysis in neurons undergoing excitotoxic cell death. We found that most proteolytically processed proteins in excitotoxic neurons are likely substrates of calpains, including key synaptic regulatory proteins such as CRMP2, doublecortin-like kinase I, Src tyrosine kinase and calmodulin-dependent protein kinase IIβ (CaMKIIβ). Critically, calpain-catalyzed proteolytic processing of these proteins generates stable truncated fragments with altered activities that potentially contribute to neuronal death by perturbing synaptic organization and function. Blocking calpain-mediated proteolysis of one of these proteins, Src, protected against neuronal loss in a rat model of neurotoxicity. Extrapolation of our N-terminomic results led to the discovery that CaMKIIα, an isoform of CaMKIIβ, undergoes differential processing in mouse brains under physiological conditions and during ischemic stroke. In summary, by identifying the neuronal proteins undergoing proteolysis during excitotoxicity, our findings offer new insights into excitotoxic neuronal death mechanisms and reveal potential neuroprotective targets for neurological disorders.
- Published
- 2023
44. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry
- Author
-
Lip G. Y. H., Kotalczyk A., Teutsch C., Diener H. -C., Dubner S. J., Halperin J. L., Ma C. -S., Rothman K. J., Marler S., Gurusamy V. K., Huisman M. V., Abban D. W., Aziz E., Kalan M. B., Abdul N., Backes L. M., Bradman D., Abud A. M., Badings E., Brautigam D., Adams F., Bagni E., Breton N., Addala S., Baker S. H., Brouwers P. J. A. M., Adragao P., Bala R., Browne K., Ageno W., Baldi A., Cortada J. B., Aggarwal R., Bando S., Bruni A., Agosti S., Banerjee S., Brunschwig C., Agostoni P., Bank A., Buathier H., Aguilar F., Esquivias G. B., Buhl A., Linares J. A., Barr C., Bullinga J., Aguinaga L., Bartlett M., Cabrera J. W., Ahmed J., Basic Kes V., Caccavo A., Aiello A., Baula G., Cai S., Ainsworth P., Behrens S., Caine S., Aiub J. R., Bell A., Calo L., Al-Dallow R., Benedetti R., Calvi V., Alderson L., Mazuecos J. B., Sanchez M. C., Velasco J. A. A., Benhalima B., Candeias R., Alexopoulos D., Bergler-Klein J., Capuano V., Manterola F. A., Berneau J. -B., Capucci A., Aliyar P., Bernstein R. A., Caputo R., Alonso D., Berrospi P., Rizo T. C., da Costa F. A. A., Berti S., Cardona F., Amado J., Berz A., da Costa Darrieux F. C., Amara W., Best E., Vera Y. C. D., Amelot M., Bettencourt P., Carolei A., Amjadi N., Betzu R., Carreno S., Ammirati F., Bhagwat R., Carvalho P., Andrade M., Bhatta L., Cary S., Andrawis N., Biscione F., Casu G., Annoni G., Bisignani G., Cavallini C., Ansalone G., Black T., Cayla G., Ariani M. K., Bloch M. J., Celentano A., Arias J. C., Bloom S., Cha T. -J., Armero S., Blumberg E., Cha K. S., Arora C., Bo M., Chae J. K., Aslam M. S., Bohmer E., Chalamidas K., Asselman M., Bollmann A., Challappa K., Audouin P., Bongiorni M. G., Chand S. P., Augenbraun C., Boriani G., Chandrashekar H., Aydin S., Boswijk D. J., Chartier L., Bott J., Chatterjee K., Ayryanova I., Bottacchi E., Ayala C. A. C., Cheema A., Davis G., Evonich R., Davy J. -M., Evseeva O., Chen L., Dayer M., Ezhov A., Chen S. -A., De Biasio M., Fahmy R., Chen J. H., De Bonis S., Fang Q., Chiang F. -T., De Caterina R., Farsad R., Chiarella F., De Franceschi T., Fauchier L., Chih-Chan L., de Groot J. R., Favale S., Cho Y. K., De Horta J., Fayard M., Choi J. -I., De La Briolle A., Fedele J. L., Choi D. J., de la Pena Topete G., Fedele F., Chouinard G., de Paola A. A. V., Fedorishina O., Chow D. H. -F., de Souza W., Fera S. R., Chrysos D., de Veer A., Ferreira L. G. G., Chumakova G., De Wolf L., Ferreira J., Valenzuela E. J. J. R. C., Decoulx E., Ferri C., Nica N. C., Deepak S., Ferrier A., Cislowski D. J., Defaye P., Ferro H., Clay A., Munoz F. D. -C., Finsen A., Clifford P., Brkljacic D. D., First B., Cohen A., Deumite N. J., Fischer S., Cohen M., Di Legge S., Fonseca C., Cohen S., Diemberger I., Almeida L. F., Colivicchi F., Dietz D., Forman S., Collins R., Dionisio P., Frandsen B., Colonna P., Dong Q., French W., Compton S., dos Santos F. R., Friedman K., Connolly D., Dotcheva E., Friese A., Conti A., Doukky R., Fruntelata A. G., Buenostro G. C., D'Souza A., Fujii S., Coodley G., Dubrey S., Fumagalli S., Cooper M., Ducrocq X., Fundamenski M., Coronel J., Dupljakov D., Furukawa Y., Corso G., Duque M., Gabelmann M., Sales J. C., Dutta D., Gabra N., Cottin Y., Duvilla N., Gadsboll N., Covalesky J., Duygun A., Galinier M., Cracan A., Dziewas R., Gammelgaard A., Crea F., Eaton C. B., Ganeshkumar P., Crean P., Eaves W., Gans C., Crenshaw J., Ebels-Tuinbeek L. A., Quintana A. G., Cullen T., Ehrlich C., Gartenlaub O., Darius H., Eichinger-Hasenauer S., Gaspardone A., Dary P., Eisenberg S. J., Genz C., Dascotte O., Jabali A. E., Georger F., Dauber I., Shahawy M. E., Georges J. -L., Davalos V., Hernandes M. E., Georgeson S., Davies R., Izal A. E., Giedrimas E., Gierba M., Haruna T., Jarmukli N., Ortega I. G., Hayek E., Jeanfreau R. J., Gillespie E., Healey J., Jenkins R. D., Giniger A., Hearne S., Sanchez C. J., Giudici M. C., Heffernan M., Jimenez J., Gkotsis A., Heggelund G., Jobe R., Glotzer T. V., Heijmeriks J. A., Joen-Jakobsen T., Gmehling J., Hemels M., Jones N., Gniot J., Hendriks I., Jorge J. C. M., Goethals P., Henein S., Jouve B., Goldbarg S., Her S. -H., Jung B. C., Goldberg R., Hermany P., Jung K. T., Goldmann B., Del Rio J. E. H., Jung W., Golitsyn S., Higashino Y., Kachkovskiy M., Gomez S., Hill M., Kafkala K., Mesa J. G., Hisadome T., Kalinina L., Gonzalez V. B., Hishida E., Kallmunzer B., Hermosillo J. A. G., Hoffer E., Kamali F., Lopez V. M. G., Hoghton M., Kamo T., Gorka H., Hong K., Kampus P., Gornick C., Hong S., Kashou H., Gorog D., Horbach S., Kastrup A., Gottipaty V., Horiuchi M., Katsivas A., Goube P., Hou Y., Kaufman E., Goudevenos I., Hsing J., Kawai K., Graham B., Huang C. -H., Kawajiri K., Greer G. S., Huckins D., Kazmierski J. F., Gremmler U., Hughes K., Keeling P., Grena P. G., Huizinga A., Saraiva J. F. K., Grond M., Hulsman E. L., Ketova G., Gronda E., Hung K. -C., Khaira A. S., Gronefeld G., Hwang G. -S., Khripun A., Gu X., Ikpoh M., Kim D. -I., Torres I. G. T., Imberti D., Kim Y. H., Guardigli G., Ince H., Kim N. H., Guevara C., Indolfi C., Kim D. K., Guignier A., Inoue S., Kim J. S., Gulizia M., Irles D., Gumbley M., Iseki H., Kim K. S., Gunther A., Israel C. N., Kim J., Ha A., Iteld B., Kinova E., Hahalis G., Iyer V., Klein A., Hakas J., Jackson-Voyzey E., Kmetzo J. J., Hall C., Jaffrani N., Kneller G. L., Han B., Jager F., Knezevic A., Han S., James M., Koh S. M. A., Hargrove J., Jang S. -W., Koide S., Hargroves D., Jaramillo N., Kollias A., Kooistra J. A., Li W., McClure J., Koons J., Li X., McCormack T., Koschutnik M., Lichy C., McGarity W., Kostis W. J., Lieber I., McIntyre H., Kovacic D., Rodriguez R. H. L., McLaurin B., Kowalczyk J., Lin H., Alvaro F., Palomino M., Koziolova N., Melandri F., Kraft P., Liu F., Meno H., Kragten J. A., Liu H., Menzies D., Krantz M., Esperon G. L., Mercader M., Krause L., Navarro N. L., Meyer C., Krenning B. J., Lo E., Meyer B. J., Krikke F., Lokshyn S., Miarka J., Kromhout Z., Lopez A., Mibach F., Krysiak W., Lopez-Sendon J. L., Michalski D., Kumar P., Filho A. M. L., Michel P., Kumler T., Lorraine R. S., Chreih R. M., Kuniss M., Luengas C. A., Luengas A., Mikdadi G., Kuo J. -Y., Luke R., Mikus M., Kuppers A., Luo M., Milicic D., Kurrelmeyer K., Lupovitch S., Militaru C., Kwak C. H., Lyrer P., Minaie S., Laboulle B., Ma C., Minescu B., Labovitz A., Ma G., Mintale I., Ter Lai W., Madariaga I., Mirault T., Lam A., Maeno K., Mirro M. J., Lam Y. Y., Magnin D., Mistry D., Lanas Zanetti F., Maid G., Miu N. V., Landau C., Mainigi S. K., Miyamoto N., Landini G., Makaritsis K., Moccetti T., Lanna Figueiredo E., Malhotra R., Mohammed A., Larsen T., Manning R., Nor A. M., Lavandier K., Manolis A., Mollerus M., LeBlanc J., Hurtado H. A. M., Molon G., Lee M. H., Mantas I., Mondillo S., Lee C. -H., Jattin F. M., Moniz P., Lehman J., Maqueda V., Mont L., Leitao A., Marchionni N., Montagud V., Lellouche N., Ortuno F. M., Montana O., Lelonek M., Santana A. M., Monti C., Lenarczyk R., Martinez J., Moretti L., Lenderink T., Maskova P., Mori K., Gonzalez S. L., Hernandez N. M., Moriarty A., Leong-Sit P., Matsuda K., Morka J., Leschke M., Maurer T., Moschini L., Ley N., Mauro C., Moschos N., Li Z., May E., Mugge A., Mayer N., Mulhearn T. J., Muresan C., Jose E. P., Precoma D. B., Muriago M., Padilla F. G. P., Prelle A., Musial W., Rios V. P., Prodafikas J., Musser C. W., Pajes G., Protasov K., Musumeci F., Pandey A. S., Pye M., Nageh T., Paparella G., Qiu Z., Nakagawa H., Paris F., Quedillac J. -M., Nakamura Y., Park H. W., Raev D., Nakayama T., Park J. S., Grado C. A. R., Nam G. -B., Parthenakis F., Rahimi S., Nanna M., Passamonti E., Raisaro A., Natarajan I., Patel R. J., Rama B., Nayak H. M., Patel J., Ramos R., Naydenov S., Patel M., Ranieri M., Nazlic J., Patrick J., Raposo N., Nechita A. C., Jimenez R. P., Rashba E., Nechvatal L., Paz A., Rauch-Kroehnert U., Negron S. A., Pengo V., Reddy R., Neiman J., Pentz W., Renda G., Neuenschwander F. C., Perez B., Reza S., Neves D., Rios A. M. P., Ria L., Neykova A., Perez-Cabezas A., Richter D., Miguel R. N., Perlman R., Rickli H., Nijmeh G., Persic V., Rieker W., Nizov A., Perticone F., Vera T. R., Campos R. N., Peters T. K., Ritt L. E., Nossan J., Petkar S., Roberts D., Novikova T., Pezo L. F., Briones I. R., Nowalany-Kozielska E., Pflucke C., Escudero A. E. R., Nsah E., Pham D. N., Pascual C. R., Fragoso J. C. N., Phillips R. T., Roman M., Nurgalieva S., Phlaum S., Romeo F., Nuyens D., Pieters D., Ronner E., Nyvad O., Pineau J., Roux J. -F., de Los Rios Ibarra M. O., Pinter A., Rozkova N., O'Donnell P., Pinto F., Rubacek M., O'Donnell M., Pisters R., Rubalcava F., Oh S., Pivac N., Russo A. M., Oh Y. S., Pocanic D., Rutgers M. P., Oh D., Podoleanu C., Rybak K., O'Hara G., Politano A., Said S., Oikonomou K., Poljakovic Z., Sakamoto T., Olivares C., Pollock S., Salacata A., Oliver R., Garcea J. P., Salem A., Ruiz R. O., Poppert H., Bodes R. S., Olympios C., Porcu M., Saltzman M. A., Omaszuk-Kazberuk A., Reino A. P., Salvioni A., Asensi J. O., Prasad N., Vallejo G. S., Fernandez M. S., Sokal A., Tu T. M., Saporito W. F., Yan Y. S. O., Tuininga Y., Sarikonda K., Sotolongo R., Turakhia M., Sasaoka T., de Souza O. F., Turk S., Sati H., Sparby J. A., Turner W., Savelieva I., Spinar J., Tveit A., Scala P. -J., Sprigings D., Tytus R., Schellinger P., Spyropoulos A. C., Valadao C., Scherr C., Stakos D., van Bergen P. F. M. M., Schmitz L., Steinwender C., van de Borne P., Schmitz K. -H., Stergiou G., van den Berg B. J., Schmitz B., Stiell I., van der Zwaan C., Schnabel T., Stoddard M., Van Eck M., Schnupp S., Stoikov A., Vanacker P., Schoeniger P., Streb W., Vasilev D., Schon N., Styliadis I., Vasilikos V., Schwimmbeck P., Su G., Vasilyev M., Seamark C., Su X., Veerareddy S., Searles G., Sudnik W., Mino M. V., Seidl K. -H., Sukles K., Venkataraman A., Seidman B., Sun X., Verdecchia P., Sek J., Swart H., Versaci F., Sekaran L., Szavits-Nossan J., Vester E. G., Serrati C., Taggeselle J., Vial H., Shah N., Takagi Y., Victory J., Shah V., Takhar A. P. S., Villamil A., Shah A., Tamm A., Vincent M., Shah S., Tanaka K., Vlastaris A., Sharma V. K., Tanawuttiwat T., Dahl J., Shaw L., Tang S., Vora K., Sheikh K. H., Tang A., Vranian R. B., Shimizu N., Tarsi G., Wakefield P., Shimomura H., Tassinari T., Wang N., Shin D. -G., Tayal A., Wang M., Shin E. -S., Tayebjee M., Wang X., Shite J., Berg J. M., Wang F., Sibilio G., Tesloianu D., Wang T., Silver F., The S. H. K., Warner A. L., Sime I., Thomas D., Watanabe K., Simmers T. A., Timsit S., Wei J., Singh N., Tobaru T., Weimar C., Siostrzonek P., Tomasik A. R., Weiner S., Smadja D., Torosoff M., Weinrich R., Smith D. W., Touze E., Wen M. -S., Snitman M., Trendafilova E., Wiemer M., Filho D. S., Tsai W. K., Wiggers P., Soda H., Tse H. F., Wilke A., Sofley C., Tsutsui H., Williams D., Williams M. L., Yan P. Y. B., Zhang P., Witzenbichler B., Yang T., Zhang J., Wong B., Yao J., Zhao S. P., Wong K. S. L., Yeh K. -H., Zhao Y., Wozakowska-Kaplon B., Yin W. H., Zhao Z., Wu S., Yotov Y., Zheng Y., Wu R. C., Zahn R., Zhou J., Wunderlich S., Zarich S., Zimmermann S., Wyatt N., Zenin S., Zini A., Wylie J., Zeuthen E. L., Zizzo S., Xu Y., Zhang H., Zong W., Xu X., Zhang D., Zukerman L. S., Yamanoue H., Zhang X., Yamashita T., Cardiology, ACS - Heart failure & arrhythmias, Lip G.Y.H., Kotalczyk A., Teutsch C., Diener H.-C., Dubner S.J., Halperin J.L., Ma C.-S., Rothman K.J., Marler S., Gurusamy V.K., Huisman M.V., Abban D.W., Aziz E., Kalan M.B., Abdul N., Backes L.M., Bradman D., Abud A.M., Badings E., Brautigam D., Adams F., Bagni E., Breton N., Addala S., Baker S.H., Brouwers P.J.A.M., Adragao P., Bala R., Browne K., Ageno W., Baldi A., Cortada J.B., Aggarwal R., Bando S., Bruni A., Agosti S., Banerjee S., Brunschwig C., Agostoni P., Bank A., Buathier H., Aguilar F., Esquivias G.B., Buhl A., Linares J.A., Barr C., Bullinga J., Aguinaga L., Bartlett M., Cabrera J.W., Ahmed J., Basic Kes V., Caccavo A., Aiello A., Baula G., Cai S., Ainsworth P., Behrens S., Caine S., Aiub J.R., Bell A., Calo L., Al-Dallow R., Benedetti R., Calvi V., Alderson L., Mazuecos J.B., Sanchez M.C., Velasco J.A.A., Benhalima B., Candeias R., Alexopoulos D., Bergler-Klein J., Capuano V., Manterola F.A., Berneau J.-B., Capucci A., Aliyar P., Bernstein R.A., Caputo R., Alonso D., Berrospi P., Rizo T.C., da Costa F.A.A., Berti S., Cardona F., Amado J., Berz A., da Costa Darrieux F.C., Amara W., Best E., Vera Y.C.D., Amelot M., Bettencourt P., Carolei A., Amjadi N., Betzu R., Carreno S., Ammirati F., Bhagwat R., Carvalho P., Andrade M., Bhatta L., Cary S., Andrawis N., Biscione F., Casu G., Annoni G., Bisignani G., Cavallini C., Ansalone G., Black T., Cayla G., Ariani M.K., Bloch M.J., Celentano A., Arias J.C., Bloom S., Cha T.-J., Armero S., Blumberg E., Cha K.S., Arora C., Bo M., Chae J.K., Aslam M.S., Bohmer E., Chalamidas K., Asselman M., Bollmann A., Challappa K., Audouin P., Bongiorni M.G., Chand S.P., Augenbraun C., Boriani G., Chandrashekar H., Aydin S., Boswijk D.J., Chartier L., Bott J., Chatterjee K., Ayryanova I., Bottacchi E., Ayala C.A.C., Cheema A., Davis G., Evonich R., Davy J.-M., Evseeva O., Chen L., Dayer M., Ezhov A., Chen S.-A., De Biasio M., Fahmy R., Chen J.H., De Bonis S., Fang Q., Chiang F.-T., De Caterina R., Farsad R., Chiarella F., De Franceschi T., Fauchier L., Chih-Chan L., de Groot J.R., Favale S., Cho Y.K., De Horta J., Fayard M., Choi J.-I., De La Briolle A., Fedele J.L., Choi D.J., de la Pena Topete G., Fedele F., Chouinard G., de Paola A.A.V., Fedorishina O., Chow D.H.-F., de Souza W., Fera S.R., Chrysos D., de Veer A., Ferreira L.G.G., Chumakova G., De Wolf L., Ferreira J., Valenzuela E.J.J.R.C., Decoulx E., Ferri C., Nica N.C., Deepak S., Ferrier A., Cislowski D.J., Defaye P., Ferro H., Clay A., Munoz F.D.-C., Finsen A., Clifford P., Brkljacic D.D., First B., Cohen A., Deumite N.J., Fischer S., Cohen M., Di Legge S., Fonseca C., Cohen S., Diemberger I., Almeida L.F., Colivicchi F., Dietz D., Forman S., Collins R., Dionisio P., Frandsen B., Colonna P., Dong Q., French W., Compton S., dos Santos F.R., Friedman K., Connolly D., Dotcheva E., Friese A., Conti A., Doukky R., Fruntelata A.G., Buenostro G.C., D'Souza A., Fujii S., Coodley G., Dubrey S., Fumagalli S., Cooper M., Ducrocq X., Fundamenski M., Coronel J., Dupljakov D., Furukawa Y., Corso G., Duque M., Gabelmann M., Sales J.C., Dutta D., Gabra N., Cottin Y., Duvilla N., Gadsboll N., Covalesky J., Duygun A., Galinier M., Cracan A., Dziewas R., Gammelgaard A., Crea F., Eaton C.B., Ganeshkumar P., Crean P., Eaves W., Gans C., Crenshaw J., Ebels-Tuinbeek L.A., Quintana A.G., Cullen T., Ehrlich C., Gartenlaub O., Darius H., Eichinger-Hasenauer S., Gaspardone A., Dary P., Eisenberg S.J., Genz C., Dascotte O., Jabali A.E., Georger F., Dauber I., Shahawy M.E., Georges J.-L., Davalos V., Hernandes M.E., Georgeson S., Davies R., Izal A.E., Giedrimas E., Gierba M., Haruna T., Jarmukli N., Ortega I.G., Hayek E., Jeanfreau R.J., Gillespie E., Healey J., Jenkins R.D., Giniger A., Hearne S., Sanchez C.J., Giudici M.C., Heffernan M., Jimenez J., Gkotsis A., Heggelund G., Jobe R., Glotzer T.V., Heijmeriks J.A., Joen-Jakobsen T., Gmehling J., Hemels M., Jones N., Gniot J., Hendriks I., Jorge J.C.M., Goethals P., Henein S., Jouve B., Goldbarg S., Her S.-H., Jung B.C., Goldberg R., Hermany P., Jung K.T., Goldmann B., Del Rio J.E.H., Jung W., Golitsyn S., Higashino Y., Kachkovskiy M., Gomez S., Hill M., Kafkala K., Mesa J.G., Hisadome T., Kalinina L., Gonzalez V.B., Hishida E., Kallmunzer B., Hermosillo J.A.G., Hoffer E., Kamali F., Lopez V.M.G., Hoghton M., Kamo T., Gorka H., Hong K., Kampus P., Gornick C., Hong S., Kashou H., Gorog D., Horbach S., Kastrup A., Gottipaty V., Horiuchi M., Katsivas A., Goube P., Hou Y., Kaufman E., Goudevenos I., Hsing J., Kawai K., Graham B., Huang C.-H., Kawajiri K., Greer G.S., Huckins D., Kazmierski J.F., Gremmler U., Hughes K., Keeling P., Grena P.G., Huizinga A., Saraiva J.F.K., Grond M., Hulsman E.L., Ketova G., Gronda E., Hung K.-C., Khaira A.S., Gronefeld G., Hwang G.-S., Khripun A., Gu X., Ikpoh M., Kim D.-I., Torres I.G.T., Imberti D., Kim Y.H., Guardigli G., Ince H., Kim N.H., Guevara C., Indolfi C., Kim D.K., Guignier A., Inoue S., Kim J.S., Gulizia M., Irles D., Gumbley M., Iseki H., Kim K.S., Gunther A., Israel C.N., Kim J., Ha A., Iteld B., Kinova E., Hahalis G., Iyer V., Klein A., Hakas J., Jackson-Voyzey E., Kmetzo J.J., Hall C., Jaffrani N., Kneller G.L., Han B., Jager F., Knezevic A., Han S., James M., Koh S.M.A., Hargrove J., Jang S.-W., Koide S., Hargroves D., Jaramillo N., Kollias A., Kooistra J.A., Li W., McClure J., Koons J., Li X., McCormack T., Koschutnik M., Lichy C., McGarity W., Kostis W.J., Lieber I., McIntyre H., Kovacic D., Rodriguez R.H.L., McLaurin B., Kowalczyk J., Lin H., Alvaro F., Palomino M., Koziolova N., Melandri F., Kraft P., Liu F., Meno H., Kragten J.A., Liu H., Menzies D., Krantz M., Esperon G.L., Mercader M., Krause L., Navarro N.L., Meyer C., Krenning B.J., Lo E., Meyer B.J., Krikke F., Lokshyn S., Miarka J., Kromhout Z., Lopez A., Mibach F., Krysiak W., Lopez-Sendon J.L., Michalski D., Kumar P., Filho A.M.L., Michel P., Kumler T., Lorraine R.S., Chreih R.M., Kuniss M., Luengas C.A., Luengas A., Mikdadi G., Kuo J.-Y., Luke R., Mikus M., Kuppers A., Luo M., Milicic D., Kurrelmeyer K., Lupovitch S., Militaru C., Kwak C.H., Lyrer P., Minaie S., Laboulle B., Ma C., Minescu B., Labovitz A., Ma G., Mintale I., Ter Lai W., Madariaga I., Mirault T., Lam A., Maeno K., Mirro M.J., Lam Y.Y., Magnin D., Mistry D., Lanas Zanetti F., Maid G., Miu N.V., Landau C., Mainigi S.K., Miyamoto N., Landini G., Makaritsis K., Moccetti T., Lanna Figueiredo E., Malhotra R., Mohammed A., Larsen T., Manning R., Nor A.M., Lavandier K., Manolis A., Mollerus M., LeBlanc J., Hurtado H.A.M., Molon G., Lee M.H., Mantas I., Mondillo S., Lee C.-H., Jattin F.M., Moniz P., Lehman J., Maqueda V., Mont L., Leitao A., Marchionni N., Montagud V., Lellouche N., Ortuno F.M., Montana O., Lelonek M., Santana A.M., Monti C., Lenarczyk R., Martinez J., Moretti L., Lenderink T., Maskova P., Mori K., Gonzalez S.L., Hernandez N.M., Moriarty A., Leong-Sit P., Matsuda K., Morka J., Leschke M., Maurer T., Moschini L., Ley N., Mauro C., Moschos N., Li Z., May E., Mugge A., Mayer N., Mulhearn T.J., Muresan C., Jose E.P., Precoma D.B., Muriago M., Padilla F.G.P., Prelle A., Musial W., Rios V.P., Prodafikas J., Musser C.W., Pajes G., Protasov K., Musumeci F., Pandey A.S., Pye M., Nageh T., Paparella G., Qiu Z., Nakagawa H., Paris F., Quedillac J.-M., Nakamura Y., Park H.W., Raev D., Nakayama T., Park J.S., Grado C.A.R., Nam G.-B., Parthenakis F., Rahimi S., Nanna M., Passamonti E., Raisaro A., Natarajan I., Patel R.J., Rama B., Nayak H.M., Patel J., Ramos R., Naydenov S., Patel M., Ranieri M., Nazlic J., Patrick J., Raposo N., Nechita A.C., Jimenez R.P., Rashba E., Nechvatal L., Paz A., Rauch-Kroehnert U., Negron S.A., Pengo V., Reddy R., Neiman J., Pentz W., Renda G., Neuenschwander F.C., Perez B., Reza S., Neves D., Rios A.M.P., Ria L., Neykova A., Perez-Cabezas A., Richter D., Miguel R.N., Perlman R., Rickli H., Nijmeh G., Persic V., Rieker W., Nizov A., Perticone F., Vera T.R., Campos R.N., Peters T.K., Ritt L.E., Nossan J., Petkar S., Roberts D., Novikova T., Pezo L.F., Briones I.R., Nowalany-Kozielska E., Pflucke C., Escudero A.E.R., Nsah E., Pham D.N., Pascual C.R., Fragoso J.C.N., Phillips R.T., Roman M., Nurgalieva S., Phlaum S., Romeo F., Nuyens D., Pieters D., Ronner E., Nyvad O., Pineau J., Roux J.-F., de Los Rios Ibarra M.O., Pinter A., Rozkova N., O'Donnell P., Pinto F., Rubacek M., O'Donnell M., Pisters R., Rubalcava F., Oh S., Pivac N., Russo A.M., Oh Y.S., Pocanic D., Rutgers M.P., Oh D., Podoleanu C., Rybak K., O'Hara G., Politano A., Said S., Oikonomou K., Poljakovic Z., Sakamoto T., Olivares C., Pollock S., Salacata A., Oliver R., Garcea J.P., Salem A., Ruiz R.O., Poppert H., Bodes R.S., Olympios C., Porcu M., Saltzman M.A., Omaszuk-Kazberuk A., Reino A.P., Salvioni A., Asensi J.O., Prasad N., Vallejo G.S., Fernandez M.S., Sokal A., Tu T.M., Saporito W.F., Yan Y.S.O., Tuininga Y., Sarikonda K., Sotolongo R., Turakhia M., Sasaoka T., de Souza O.F., Turk S., Sati H., Sparby J.A., Turner W., Savelieva I., Spinar J., Tveit A., Scala P.-J., Sprigings D., Tytus R., Schellinger P., Spyropoulos A.C., Valadao C., Scherr C., Stakos D., van Bergen P.F.M.M., Schmitz L., Steinwender C., van de Borne P., Schmitz K.-H., Stergiou G., van den Berg B.J., Schmitz B., Stiell I., van der Zwaan C., Schnabel T., Stoddard M., Van Eck M., Schnupp S., Stoikov A., Vanacker P., Schoeniger P., Streb W., Vasilev D., Schon N., Styliadis I., Vasilikos V., Schwimmbeck P., Su G., Vasilyev M., Seamark C., Su X., Veerareddy S., Searles G., Sudnik W., Mino M.V., Seidl K.-H., Sukles K., Venkataraman A., Seidman B., Sun X., Verdecchia P., Sek J., Swart H., Versaci F., Sekaran L., Szavits-Nossan J., Vester E.G., Serrati C., Taggeselle J., Vial H., Shah N., Takagi Y., Victory J., Shah V., Takhar A.P.S., Villamil A., Shah A., Tamm A., Vincent M., Shah S., Tanaka K., Vlastaris A., Sharma V.K., Tanawuttiwat T., Dahl J., Shaw L., Tang S., Vora K., Sheikh K.H., Tang A., Vranian R.B., Shimizu N., Tarsi G., Wakefield P., Shimomura H., Tassinari T., Wang N., Shin D.-G., Tayal A., Wang M., Shin E.-S., Tayebjee M., Wang X., Shite J., Berg J.M., Wang F., Sibilio G., Tesloianu D., Wang T., Silver F., The S.H.K., Warner A.L., Sime I., Thomas D., Watanabe K., Simmers T.A., Timsit S., Wei J., Singh N., Tobaru T., Weimar C., Siostrzonek P., Tomasik A.R., Weiner S., Smadja D., Torosoff M., Weinrich R., Smith D.W., Touze E., Wen M.-S., Snitman M., Trendafilova E., Wiemer M., Filho D.S., Tsai W.K., Wiggers P., Soda H., Tse H.F., Wilke A., Sofley C., Tsutsui H., Williams D., Williams M.L., Yan P.Y.B., Zhang P., Witzenbichler B., Yang T., Zhang J., Wong B., Yao J., Zhao S.P., Wong K.S.L., Yeh K.-H., Zhao Y., Wozakowska-Kaplon B., Yin W.H., Zhao Z., Wu S., Yotov Y., Zheng Y., Wu R.C., Zahn R., Zhou J., Wunderlich S., Zarich S., Zimmermann S., Wyatt N., Zenin S., Zini A., Wylie J., Zeuthen E.L., Zizzo S., Xu Y., Zhang H., Zong W., Xu X., Zhang D., Zukerman L.S., Yamanoue H., Zhang X., and Yamashita T.
- Subjects
Apixaban ,Atrial fibrillation ,Dabigatran ,Non-vitamin K antagonists ,Rivaroxaban ,Pyridones ,Medizin ,Myocardial Infarction ,Administration, Oral ,Anticoagulants ,Hemorrhage ,General Medicine ,Non-vitamin K antagonist ,Stroke ,Clinical Trials, Phase III as Topic ,Humans ,Prospective Studies ,Registries ,Cardiology and Cardiovascular Medicine - Abstract
Background and purpose Prospectively collected data comparing the safety and effectiveness of individual non-vitamin K antagonists (NOACs) are lacking. Our objective was to directly compare the effectiveness and safety of NOACs in patients with newly diagnosed atrial fibrillation (AF). Methods In GLORIA-AF, a large, prospective, global registry program, consecutive patients with newly diagnosed AF were followed for 3 years. The comparative analyses for (1) dabigatran vs rivaroxaban or apixaban and (2) rivaroxaban vs apixaban were performed on propensity score (PS)-matched patient sets. Proportional hazards regression was used to estimate hazard ratios (HRs) for outcomes of interest. Results The GLORIA-AF Phase III registry enrolled 21,300 patients between January 2014 and December 2016. Of these, 3839 were prescribed dabigatran, 4015 rivaroxaban and 4505 apixaban, with median ages of 71.0, 71.0, and 73.0 years, respectively. In the PS-matched set, the adjusted HRs and 95% confidence intervals (CIs) for dabigatran vs rivaroxaban were, for stroke: 1.27 (0.79–2.03), major bleeding 0.59 (0.40–0.88), myocardial infarction 0.68 (0.40–1.16), and all-cause death 0.86 (0.67–1.10). For the comparison of dabigatran vs apixaban, in the PS-matched set, the adjusted HRs were, for stroke 1.16 (0.76–1.78), myocardial infarction 0.84 (0.48–1.46), major bleeding 0.98 (0.63–1.52) and all-cause death 1.01 (0.79–1.29). For the comparison of rivaroxaban vs apixaban, in the PS-matched set, the adjusted HRs were, for stroke 0.78 (0.52–1.19), myocardial infarction 0.96 (0.63–1.45), major bleeding 1.54 (1.14–2.08), and all-cause death 0.97 (0.80–1.19). Conclusions Patients treated with dabigatran had a 41% lower risk of major bleeding compared with rivaroxaban, but similar risks of stroke, MI, and death. Relative to apixaban, patients treated with dabigatran had similar risks of stroke, major bleeding, MI, and death. Rivaroxaban relative to apixaban had increased risk for major bleeding, but similar risks for stroke, MI, and death. Registration URL: https://www.clinicaltrials.gov. Unique identifiers: NCT01468701, NCT01671007. Date of registration: September 2013. Graphical abstract
- Published
- 2022
45. Flight behaviour monitoring and quantification of aedes aegypti using convolution neural network.
- Author
-
Javed, Nouman, Paradkar, Prasad N., and Bhatti, Asim
- Subjects
- *
CONVOLUTIONAL neural networks , *AEDES aegypti , *INTERPOLATION algorithms , *EPIDEMIOLOGICAL models , *MOSQUITOES , *SPLINE theory - Abstract
Mosquito-borne diseases cause a huge burden on public health worldwide. The viruses that cause these diseases impact the behavioural traits of mosquitoes, including locomotion and feeding. Understanding these traits can help in improving existing epidemiological models and developing effective mosquito traps. However, it is difficult to understand the flight behaviour of mosquitoes due to their small sizes, complicated poses, and seemingly random moving patterns. Currently, no open-source tool is available that can detect and track resting or flying mosquitoes. Our work presented in this paper provides a detection and trajectory estimation method using the Mask RCNN algorithm and spline interpolation, which can efficiently detect mosquitoes and track their trajectories with higher accuracy. The method does not require special equipment and works excellently even with low-resolution videos. Considering the mosquito size, the proposed method's detection performance is validated using a tracker error and a custom metric that considers the mean distance between positions (estimated and ground truth), pooled standard deviation, and average accuracy. The results showed that the proposed method could successfully detect and track the flying (≈ 96% accuracy) as well as resting (100% accuracy) mosquitoes. The performance can be impacted in the case of occlusions and background clutters. Overall, this research serves as an efficient open-source tool to facilitate further examination of mosquito behavioural traits. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Formulation And Evaluation Of Pulsatile Drug Delivery System Of Tolterodine Core In Cup Tablets.
- Author
-
Krosuri, Pavan Kumar, Kavya, P., Lavanya, B., devi, A. Gayathri, Meghana, P., Prasad, N., Priyadarshini, D., and Sayyed, S. Mahaboob
- Subjects
DRUG delivery systems ,ETHYLCELLULOSE ,TOLTERODINE ,DRUG solubility ,PECTINS ,LOCUST bean gum ,DRUG interactions - Abstract
Objective:The aim of the present study to prepare Pulsatile release tablets of Tolterodine tartarate for the treatment of over active bladder. Methods:The drug delivery system was designed to deliver the drug at time when it could be most needful for the patient. Tolterodine Tartarate Pulsatile core-in-cup tablet was designed to deliver a rapid or transient and quantified drug after a predetermined lag period. This type of tablet was prepared by direct compression method and is used to prepare a set of corein- cup tablets with Swellable and Rupturable polymers like Pectin, Locust bean gum and HPMCK15M respectively with different proportions with impermeable cup ethyl cellulose. Tablets were evaluated for Precompression, Post compression and in vitro dissolution studies. Results: The drug polymer interaction was studied by FTIR. The Precompression and post compression parameters are with in the limits.The Data of core-in-cup tablet were within the acceptable limit and they can be compressed directly into tablets. The hardness, friability and uniformity in weight and disintegration time results were in accordance with the standard limit. The lag time is dependent on rupturing property of Ethylcellulose and swelling property of the polymers. In the Optimized formulation the best fit model was found to be Korsmeyer peppas with exponential 'n' value is > 1 indicates the drug release follows super case II transport mechanism. The initial burst release was observed after lag time and drug release of 9was extended up to 11hrs for the optimized formulation. The in vitro drug release studies suggest that core-in-cup tablet prepared with ethyl cellulose and HPMC K 15 M shows a lag time of 4hrs due to more swelling and delayed rupturing properties of HPMC K15M and ethyl cellulose. Comparitive Dissolution studies were conducted for optimized formulation TT9 & Marketed preparation. Short Term Stability studies indicate no significant changes in Drug content and Dissolution rates. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Performance of Boiler efficiency in Thermal Power PlantV.
- Author
-
KUMAR, DIVYA PRAKASH, KUMAR, J. LIKHIN, PRASAD, N. DURGA, CHANDRA EKANTH, S. LAKSHMI, BHASKAR, D. UDAY, RAKESH, J., ABHINASH, K., and Naveen, P. N. E.
- Subjects
BOILER efficiency ,THERMAL efficiency ,ENERGY industries ,ENERGY conservation ,POWER resources ,THERMAL coal ,INDUSTRIAL energy consumption - Abstract
The world over energy resources are getting scarcer and increasingly exorbitant with time. In India bridging the ever- widening gap between energy demand and supply by increasing supply is an expensive option. The share of energy costs in total production costs can, therefore improve profit levels in all the industries. Thermal Power Plant is a major source of electricity production by coal. We will understand the overview of Thermal Power Plant i.e its parts such as boiler, turbine etc. Overview of Thermal Power Plant is very important for its better functioning and for its maintenance. The satisfactory design consist of selection of sites; estimation of cost; selection of Boiler, Turbine, Electrical Generator, Cooling System. The Transportation of electrical energy is more economical to the transportation of coal. So, we have to put greater efforts on thermal power plant as it is very economical for us. This reduction can be achieved by improving the efficiency of industrial operations and equipments. Energy plays an important role in identifying energy conservation opportunities in the industrial sector, while they do not provide the final answer to the problem; they do help to identify potential for energy conservation and induces the companies to concentrate their efforts in this area in a focused manner. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. The effect of an adaptation to hypoxia on cardiac tolerance to ischemia/reperfusion.
- Author
-
Naryzhnaya, Natalia V., Maslov, Leonid N., Derkachev, Ivan A., Huijie Ma, Yi Zhang, Prasad, N. Rajendra, Singh, Nirmal, Feng Fu, Jianming Pei, Sarybaev, Akpay, and Sydykov, Akylbek
- Subjects
RIGHT ventricular hypertrophy ,REPERFUSION ,MYOCARDIAL infarction ,ISCHEMIA ,HYPOXEMIA - Abstract
The acute myocardial infarction (AMI) and sudden cardiac death (SCD), both associated with acute cardiac ischemia, are one of the leading causes of adult death in economically developed countries. The development of new approaches for the treatment and prevention of AMI and SCD remains the highest priority for medicine. A study on the cardiovascular effects of chronic hypoxia (CH) may contribute to the development of these methods. Chronic hypoxia exerts both positive and adverse effects. The positive effects are the infarct-reducing, vasoprotective, and antiarrhythmic effects, which can lead to the improvement of cardiac contractility in reperfusion. The adverse effects are pulmonary hypertension and right ventricular hypertrophy. This review presents a comprehensive overview of how CH enhances cardiac tolerance to ischemia/reperfusion. It is an indepth analysis of the published data on the underlying mechanisms, which can lead to future development of the cardioprotective effect of CH. A better understanding of the CH-activated protective signaling pathways may contribute to new therapeutic approaches in an increase of cardiac tolerance to ischemia/reperfusion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
49. Clinical Outcomes of T-Cell-Mediated Rejection in Renal Allografts.
- Author
-
Fernando, Edwin, Chiniwalar, Archana, Annadurai, Poongodi, Valavan, K. Thirumal, Surendran, Sujit, and Prasad, N. D. Srinivasa
- Subjects
GRAFT rejection ,HOMOGRAFTS ,ANALYSIS of variance ,KIDNEY transplantation ,RETROSPECTIVE studies ,FISHER exact test ,TREATMENT effectiveness ,T-test (Statistics) ,CHI-squared test ,DESCRIPTIVE statistics ,T cells ,DATA analysis software ,TACROLIMUS - Abstract
Background: T-cell-mediated rejection (TCMR) occurs in 10%-12% of renal allografts. TCMR manifests as a rise in serum creatinine, decreased urine output, fever, and graft tenderness. It has a negative impact on long-term allograft function. Hence, we did a retrospective analysis of patients with TCMR to know the pattern, risk factors, and treatment outcome. Materials and Methods: We analyzed retrospectively clinical characteristics, laboratory data, renal biopsy reports, precipitating factors, treatment modalities, and outcomes from case records and biopsy registers of 30 patients with TCMR between July 2019 and June 2021 in our institution. Results: Out of 30 patients studied, 80% were males and 20% were females. The mean age was 29.67 ± 8.8 years. Live-related renal transplantation accounted for 80% of patients. Native kidney disease was not known in 63%. The mean duration of rejection was 21.73 ± 23.24 months. Among the various risk factors studied, low tacrolimus levels were seen in 56.7%, which was statistically significant (P < 0.05). All the patients were treated for rejection, and improvement was seen in most and 10.7% showed no improvement. Conclusion: Most patients with TCMR improved with treatment. Inadequate immunosuppression was the risk factor for TCMR in the maximum number of our patients. Compliance was good in most patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
50. IoT based Attendance Monitoring System
- Author
-
Bala Ganesh A, Nishanth S, and Vishnu Prasad N
- Subjects
RFID ,IoT ,IoT based Attendance Monitoring System ,Attendance ,Attendance Monitoring system - Abstract
Most agencies combat the delicate device of retaining their guide attendance scholars. The manual approach of subscribing to the paper is long-lasting and unsafe. A high-quality attendance monitoring gadget ought to be done in “analogous places”. An RFID (Radio Frequency Identification) predicated go-to gadget the usage of the IoT system is one of the consequences on deal with this issue. This paper is about the origins of the IoT- predicated Attendance Monitoring System, which identifies each persona. The pupil as having supported the RFID marker tied to their identification card. This makes the attendance recording medium royal, quick, and impenetrable compared to the ordinary system. The device is deliberate to be used in several instructional establishments, marketable services, government services, etc. The proposed technique consists of assault elements that assist IoT technology. “The attack issue includes the EM-18 RFID card florilegium and RFID labels/cards”. Scholars ought to place their RFID card or marker on the florilegium and their presence will be documented the everyday. Also, the recorded visit is extra specific due to the fact the technique syncs with the real-time timer the usage of the RTC (Remote Time Clock) module.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.